Utility of Salivary Biomarkers for Demonstrating Acute Myocardial Infarction

Journal of Dental Research

Volumn 93, Issue , 2014, Pages 72S-79S

  Miller, C S ^a   Foley, J D ^b   Floriano, P N ^c   Christodoulides, N ^c   Ebersole, J L ^a   Campbell, C L ^b   Bailey, A L ^b   Rose, B G ^d   Kinane, D F ^d   Novak, M J ^a   Mcdevitt, J T ^c,e   Ding, X ^f   Kryscio, R J ^f,g  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c RICE UNIVERSITY   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

Author keywords

biological markers; coronary disease; diagnosis; early diagnosis; saliva; serum

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD40 LIGAND; CREATINE KINASE MB; SALIVA PROTEIN; TROPONIN I;

ADULT; AGED; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DECISION TREE; DENTITION; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HEALTH; HEALTH STATUS; HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROCEDURES; SALIVA; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING;

ADULT; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CD40 LIGAND; COHORT STUDIES; CREATINE KINASE, MB FORM; CROSS-SECTIONAL STUDIES; DECISION TREES; DENTITION; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; ORAL HEALTH; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SMOKING; TROPONIN I;

EID: 84964315770     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514537522     Document Type: Article

References (31)

1. Antman EM Anbe DT Armstrong PW Bates ER Green LA Hand M. (2004). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44: 671-719; erratum in J Am Coll Cardiol 45:1376, 2005.
2. Buduneli E Mantyla P Emingil G Tervahartiala T Pussinen P Baris N. (2011). Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level. J Periodontol 82: 716-725.
3. Burke FJ Busby M McHugh S Delargy S Mullins A Matthews R (2003). Evaluation of an oral health scoring system by dentists in general dental practice. Br Dent J 194: 215-218.
4. De Luca G Gibson MC Hof AW Cutlip D Zeymer U Noc M. (2013). Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors. J Cardiovasc Med 14: 815-820.
5. Diercks DB Kirk JD Lindsell CJ Pollack CV Jr Hoekstra JW Gibler WB. (2006). Door-to-ECG time in patients with chest pain presenting to the ED. Am J Emerg Med 24: 1-7.
6. Eitel I Franke A Schuler G Thiele H (2010). ST-segment resolution and prognosis after facilitated versus primary percutaneous coronary intervention in acute myocardial infarction: a meta-analysis. Clin Res Cardiol 99: 1-11.
7. Floriano PN Christodoulides N Miller CS Ebersole JL Spertus J Rose BG. (2009). Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem 55: 1530-1538.
8. Foley JD III Sneed JD Steinhubl SR Kolasa J Ebersole JL Lin Y. (2012a). Oral fluids that detect cardiovascular disease biomarkers. Oral Surg Oral Med Oral Pathol Oral Radiol 114: 207-214.
9. Foley JD III Sneed JD Steinhubl SR Kolasa JR Ebersole JL Lin Y. (2012b). Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model. Oral Surg Oral Med Oral Pathol Oral Radiol 114: 616-623.
10. Go AS Mozaffarian D Roger VL Benjamin EJ Berry JD Blaha MJ. (2014). Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 129: e28-e292.
11. Hu S Xie Y Ramachandran P Ogorzalek Loo RR Li Y Loo JA. (2005). Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 5: 1714-1728.
12. Jacobs AK Antman EM Faxon DP Gregory T Solis P (2007). Development of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation 116: 217-230.
13. Menees DS Peterson ED Wang Y Curtis JP Messenger JC Rumsfeld JS. (2013). Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med 369: 901-909.
14. Miller C.S. Foley JD Bailey AL Campell CL Humphries RL Christodoulides N. (2010). Current developments in salivary diagnostics. Biomark Med 4: 171-189.
15. Mirzaii-Dizgah I Jafari-Sabet M (2011). Unstimulated whole saliva creatine phosphokinase in acute myocardial infarction. Oral Dis 17: 597-600.
16. Mirzaii-Dizgah I Riahi E (2013a). Salivary high-sensitivity cardiac troponin T levels in patients with acute myocardial infarction. Oral Dis 19: 180-184.
17. Mirzaii-Dizgah I Riahi E (2013b). Salivary troponin I as an indicator of myocardial infarction. Indian J Med Res 138: 861-865.
18. Mirzaii-Dizgah I Hejazi SF Riahi E Salehi MM (2012). Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction. Clin Oral Investig 16: 775-779.
19. Morrow DA Braunwald E (2003). Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 108: 250-252.
20. Motiwala SR Sarma A Januzzi JL O'Donoghue ML (2013). Biomarkers in ACS and heart failure: Should men and women be interpreted differently? Clin Chem 60: 35-43.
21. Orford JL Sesso HD Stedman M Gagnon D Vokonas P Gaziano JM (2002). A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 144: 95-100.
22. Sabatine MS Morrow DA de Lemos JA Gibson CM Murphy SA Rifai N. (2002). Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105: 1760-1763.
23. Shen YS Chen WL Chang HY Kuo HY Chang YC Chu H (2012). Diagnostic performance of initial salivary alpha-amylase activity for acute myocardial infarction in patients with acute chest pain. J Emerg Med 43: 553-560.
24. Storrow AB Lindsell CJ Han JH Slovis CM Miller KF Gibler WB. (2006). Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. Ann Emerg Med 48: 660-665.
25. Straface AL Myers JH Kirchick HJ Blick KE (2008). A rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department. Am J Clin Pathol 129: 788-795.
26. Ting HH Krumholz HM Bradley EH Cone DC Curtis JP Drew BJ. (2008). Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Circulation 118: 1066-1079.
27. Toker A Aribas A Yerlikaya FH Tasyurek E Akbuga K (2013). Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction. J Clin Lab Anal 27: 99-104.
28. Wilper AP Woolhandler S Lasser KE McCormick D Cutrona SL Bor DH. (2008). Waits to see an emergency department physician: U.S. trends and predictors, 1997-2004. Health Aff (Millwood) 27: w84-w95.
29. Wu AH (2007). Early detection of acute coronary syndromes and risk stratification by multimarker analysis. Biomark Med 1: 45-57.
30. Xiao H Wong DT (2011). Proteomics and its applications for biomarker discovery in human saliva. Bioinformation 5: 294-296.
31. Zoellner H (2011). Dental infection and vascular disease. Semin Thromb Hemost 37: 181-192.